Akari Therapeutics (AKTX) Beginning Cash Balance (2014 - 2015)
Akari Therapeutics' (AKTX) quarterly Beginning Cash Balance came in at $3.1 million in Q4 2015, up 42466.77% year-on-year from N/an in Q4 2014, and up 42466.77% quarter-over-quarter from -$7205.0 in Q4 2014.
Akari Therapeutics (AKTX) Beginning Cash Balance (2014 - 2015) Analysis & Trends
Akari Therapeutics has disclosed Beginning Cash Balance across 2 years of filings, most recently posting $3.1 million for Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 3.05 Mn |
| Dec 31, 2015 | 3.05 Mn |
| Dec 31, 2014 | -7,205.00 |
| Dec 31, 2014 | -7,205.00 |